Freeline Therapeutics Holdings Price on September 30, 2023

FRLNDelisted Stock  USD 4.31  0.28  6.10%   
If you're considering investing in Freeline Stock, it is important to understand the factors that can impact its price. As of today, the current price of Freeline Therapeutics stands at 4.31, as last reported on the 19th of December, with the highest price reaching 4.72 and the lowest price hitting 4.15 during the day. We have found twenty-three technical indicators for Freeline Therapeutics Holdings, which you can use to evaluate the volatility of the firm. Please confirm Freeline Therapeutics' Variance of 108.77, standard deviation of 10.43, and Mean Deviation of 5.9 to check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Freeline Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
FRLN
Based on monthly moving average Freeline Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Freeline Therapeutics by adding Freeline Therapeutics to a well-diversified portfolio.

Freeline Therapeutics Valuation on September 30, 2023

It is possible to determine the worth of Freeline Therapeutics on a given historical date. On September 30, 2023 Freeline was worth 4.59 at the beginning of the trading date compared to the closed value of 4.31. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Freeline Therapeutics stock. Still, in general, we apply an absolute valuation method to find Freeline Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Freeline Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Freeline Therapeutics' related companies.
 Open High Low Close Volume
  4.76    4.94    4.71    4.71    52,433  
07/24/2023
  4.59    4.72    4.15    4.31    81,432  
  4.59    4.72    4.15    4.31    0.00  
Backtest Freeline Therapeutics  |  Freeline Therapeutics History  |  Freeline Therapeutics Valuation   PreviousNext  
Open Value
4.59
4.31
Closing Value
4.59
Upside

Freeline Therapeutics Trading Date Momentum on September 30, 2023

On December 19 2024 Freeline Therapeutics Holdings was traded for  4.31  at the closing time. The top price for the day was 4.72  and the lowest listed price was  4.15 . There was no trading activity during the period 0.0. Lack of trading volume on December 19, 2024 did not affect price variability. The overall trading delta against the current closing price is 6.50% .

Freeline Therapeutics Fundamentals Correlations and Trends

By evaluating Freeline Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Freeline Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Freeline financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Freeline Therapeutics Stock history

Freeline Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Freeline is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Freeline Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Freeline Therapeutics stock prices may prove useful in developing a viable investing in Freeline Therapeutics
Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops transformative adeno-associated virus vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases. The company was founded in 2015 and is headquartered in Stevenage, the United Kingdom. Freeline Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 235 people.

Freeline Therapeutics Stock Technical Analysis

Freeline Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Freeline Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Freeline Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Freeline Therapeutics Period Price Range

Low
December 19, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Freeline Therapeutics Holdings cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Freeline Therapeutics December 19, 2024 Market Strength

Market strength indicators help investors to evaluate how Freeline Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Freeline Therapeutics shares will generate the highest return on investment. By undertsting and applying Freeline Therapeutics stock market strength indicators, traders can identify Freeline Therapeutics Holdings entry and exit signals to maximize returns

Freeline Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Freeline Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Freeline Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Freeline to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Consideration for investing in Freeline Stock

If you are still planning to invest in Freeline Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Freeline Therapeutics' history and understand the potential risks before investing.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Fundamental Analysis
View fundamental data based on most recent published financial statements
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Money Managers
Screen money managers from public funds and ETFs managed around the world
Volatility Analysis
Get historical volatility and risk analysis based on latest market data